OC
SBBP

Oppenheimer & Co’s Strongbridge Biopharma plc. SBBP Stock Holding History

Oppenheimer & Co’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-42,731
Closed -$102K – 1340
2019
Q3 		$102K Buy
42,731
+398
+0.9% +$1.07K ﹤0.01% 1214
2019
Q2 		$132K Sell
42,333
-3,115
-7% -$11.4K ﹤0.01% 1244
2019
Q1 		$226K Buy
45,448
+21,626
+91% +$106K 0.01% 1166
2018
Q4 		$107K Sell
23,822
-83
-0.3% -$405 ﹤0.01% 1185
2018
Q3 		$116K Buy
23,905
+9,152
+62% +$46.8K ﹤0.01% 1303
2018
Q2 		$89K Buy
14,753
+1,317
+10% +$9.64K ﹤0.01% 1293
2018
Q1 		$119K Buy
+13,436
New +$101K ﹤0.01% 1283

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Oppenheimer & Co's SBBP Position: Q4 2019 in Review

Oppenheimer & Co sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2019, closing a stake of 42,731 shares — an estimated $102K sold.

Oppenheimer & Co first reported a position in SBBP in Q1 2018 and held it in 7 quarters. The position peaked at $226K in Q1 2019. 58 funds tracked by Wall St. Rank hold SBBP as of Q4 2019.

  • Oppenheimer & Co reported no remaining Strongbridge Biopharma plc. position as of Q4 2019 after selling out during the quarter.
  • Oppenheimer & Co sold 42,731 Strongbridge Biopharma plc. shares in Q4 2019, an estimated $102K.
  • Oppenheimer & Co first reported a position in Strongbridge Biopharma plc. in Q1 2018 and held it in 7 quarters.
  • Oppenheimer & Co's Strongbridge Biopharma plc. position peaked at $226K in Q1 2019.
  • 58 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2019.

Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.